Effect of Repositioning Frequency Neonates Receiving Phototherapy

NCT05692648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-01-20

No results posted yet for this study

Summary

Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort.

Design and methods: This was a single-centered, single-blind, 3-arm, pretest-posttest parallel-group randomized controlled trial conducted in a neonatal intensive care unit. Participants were randomly assigned to one of three groups: Supine position group (n = 20), hourly position change group (n = 20), and control group (n = 20). The bilirubin level and comfort levels of the neonates were evaluated.

Conditions

  • Bilirubinemia
  • Newborn Jaundice

Interventions

BEHAVIORAL

Supine position group

These neonates were placed in supine position, fed every 2 hours in accordance with routine clinical practice, and then returned to supine position.

BEHAVIORAL

Hourly position change group

Infants in this group were repositioned "every hour" based on the time of phototherapy initiation. Neonates were initially placed in supine position and then changed to the prone position. Infants were alternated between supine and prone positions every hour for 24 hours.

BEHAVIORAL

Control Group (2-hour position change)

Neonates in this group were repositioned every 2 hours as routine practice based on the time of phototherapy initiation. Phototherapy was started with neonates in supine position. In the second period, the neonate was placed in the prone position after routine feeding was performed.

Sponsors & Collaborators

  • Selcuk University

    lead OTHER

Principal Investigators

  • Sibel Kücükoglu, professor · Selcuk University

  • Fatma Tas Arslan, professor · Selcuk University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Weeks
Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-08-30
Completion
2020-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05692648 on ClinicalTrials.gov